These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21453218)

  • 1. Current role of myeloperoxidase in routine clinical practice.
    Dominguez-Rodriguez A; Abreu-Gonzalez P
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):223-30. PubMed ID: 21453218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction.
    Goldmann BU; Rudolph V; Rudolph TK; Holle AK; Hillebrandt M; Meinertz T; Baldus S
    Free Radic Biol Med; 2009 Jul; 47(1):79-83. PubMed ID: 19362143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of myeloperoxidase in patients with chest pain.
    Brennan ML; Penn MS; Van Lente F; Nambi V; Shishehbor MH; Aviles RJ; Goormastic M; Pepoy ML; McErlean ES; Topol EJ; Nissen SE; Hazen SL
    N Engl J Med; 2003 Oct; 349(17):1595-604. PubMed ID: 14573731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myeloperoxidase as possible diagnostic and prognostic marker of acute coronary syndrome].
    Gustapane M; Cardillo MT; Biasillo G; Biasucci LM
    Recenti Prog Med; 2011 Nov; 102(11):447-50. PubMed ID: 22120783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.
    Ferrante G; Nakano M; Prati F; Niccoli G; Mallus MT; Ramazzotti V; Montone RA; Kolodgie FD; Virmani R; Crea F
    Circulation; 2010 Dec; 122(24):2505-13. PubMed ID: 21126969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase is not useful for the early assessment of patients with chest pain.
    Eggers KM; Dellborg M; Johnston N; Oldgren J; Swahn E; Venge P; Lindahl B
    Clin Biochem; 2010 Feb; 43(3):240-5. PubMed ID: 19822136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early stratification of patients with chest pain and suspected acute coronary syndrome in the Emergency Department.
    Bracco C; Melchio R; Sturlese U; Pomero F; Martini G; Poggi A; Cena P; Severini S; Castagna E; Brignone C; Serraino C; Dutto L; Veglio F; Fenoglio L
    Minerva Med; 2010 Apr; 101(2):73-80. PubMed ID: 20467407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain.
    McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
    Adv Ther; 2009 May; 26(5):531-4. PubMed ID: 19475367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New features of troponin testing in different clinical settings.
    Omland T
    J Intern Med; 2010 Sep; 268(3):207-17. PubMed ID: 20626552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac biomarkers - the old and the new: a review.
    Singh V; Martinezclark P; Pascual M; Shaw ES; O'Neill WW
    Coron Artery Dis; 2010 Jun; 21(4):244-56. PubMed ID: 20351549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parameters of platelets activation and myeloperoxidase concentration as markers of coronary disease].
    Pawlus J; Rusak M; Chociej-Stypułkowska J; Dabrowska M
    Pol Merkur Lekarski; 2010 Oct; 29(172):259-62. PubMed ID: 21207644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease.
    Pawlus J; Hołub M; Kozuch M; Dabrowska M; Dobrzycki S
    Int J Lab Hematol; 2010 Jun; 32(3):320-8. PubMed ID: 20201999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.
    Dominguez-Rodriguez A; Samimi-Fard S; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Am J Cardiol; 2008 Jun; 101(11):1537-40. PubMed ID: 18489929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-traditional biomarkers of atherosclerosis in stable and unstable coronary artery disease, do they differ?
    Konstantino Y; Wolk R; Terra SG; Nguyen TT; Fryburg DA
    Acute Card Care; 2007; 9(4):197-206. PubMed ID: 17924231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New approaches in coronary microcirculation].
    Ginghină C; Patriche M; Chreih R; Popescu BA; Deleanu D
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):711-8. PubMed ID: 20201258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers in the diagnosis of acute coronary syndrome].
    Romić E; Unić A; Derek L; Pehar M
    Acta Med Croatica; 2009 Feb; 63(1):15-9. PubMed ID: 19681456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chest pain centers: diagnosis of acute coronary syndromes.
    Storrow AB; Gibler WB
    Ann Emerg Med; 2000 May; 35(5):449-61. PubMed ID: 10783407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.